Diabetic neuropathy: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• GLP-1 0
• SGLT2 0
• AMPK 1
• CTNNB1 0
• DPP-4 0
• IDO1 0
• MMP-9 1
• NLRP3 0
• NRF2 0
• TP53 0

24 of 192 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• U.S. Department of Veterans Affairs · I01

  Targeted Degradation of Sodium Channel Nav1.8 for Analgesia

  Va Connecticut Healthcare System· West Haven, United States· until Sept 2030

• NIH NIAMS · R21

  Individualized treatment of osteoarthritis (OA) through local drug activation at disease sites: Treating OA where, and only where, it is needed

  University of Colorado· Boulder, United States· US$368,156 awarded in fiscal year 2026· until Aug 2028

• NIH NIDDK · R01

  Wearable focal vibration on mobility and pain in patients with diabetic peripheral neuropathy

  University of Florida· Gainesville, United States· US$1,497,985 awarded in fiscal year 2026· until Aug 2029

• NIH NIDDK · R01

  Glial Neuronal Crosstalk in Neuropathic Pain and Diabetes

  Duke University· Durham, United States· US$3,503,160 awarded in fiscal year 2026· until Aug 2030

• NIH NIDDK · R01

  Unveiling skin-derived SIRT1 as a therapeutic target for diabetic neuropathy

  Johns Hopkins University· Baltimore, United States· US$723,956 awarded in fiscal year 2026· until Jun 2031

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Using human iPSC-derived sensory neurons to uncover the molecular basis of mechanical hypersensitivity in chronic pain (MechanoPain-iPSC)

  The Chancellor, Masters and Scholars of the University of Oxford· Oxford, United Kingdom· EU contribution €276,188· until Sept 2028

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  A fully wearable electro-stimulating system designed to improve mobility and foot health in diabetic peripheral neuropathy patients (NEURO-SOCK)

  Medizinische Universitaet Wien· Wien, Austria· EU contribution €150,000· until Dec 2026· 2 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Diabetic neuropathy: a study on the effects of insulin resistance on its pathophysiology and a randomized clinical trial to prevent neural loss (SenseDiabetes)

  Ethniko Kai Kapodistriako Panepistimio Athinon· Athina, Greece· EU contribution €153,487· until Jan 2027

• European Commission (Horizon 2020) · ERC-COG

  Deconstructing the Translational Control of Myelination by Specialized Ribosomes (MyeRIBO)

  Universidad de Santiago de Compostela· Santiago De Compostela, Spain· EU contribution €1,874,996· until Dec 2026

  The disease is named only in the funder's project summary, not in the title.

9 of 43 running projects, newest first. Listed amounts together: US$25.9m + €2.5m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy

  NCT06715462· Eurofarma Laboratorios S.A.· Updated 18 Dec 2025

  “Strategic change in development priorities”Registry text, quoted unchanged. Source

• Terminated

  BurstDR Stimulation for Painful Diabetic Neuropathy

  NCT05985291· Wake Forest University Health Sciences· Updated 6 Nov 2025

  “Principal Investigator left Advocate Health”Registry text, quoted unchanged. Source

• Withdrawn

  A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy

  NCT05937152· Mayo Clinic· Updated 6 Mar 2025

  “no participants enrolled”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Comparative Effects Of Sensory Reweighting And Proprioceptive Facilitation Training On Balance And Fall Risk In Diabetic Peripheral Neuropathy

  NCT07896382· University of Management and Technology Lahore· Source

• Comparative Effects of tDCS and tACS on Pain, Dexterity, and Strength in Diabetic Peripheral Neuropathy

  NCT07905729· University of Management and Technology Lahore· Source

• Safety and Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for Painful Diabetic Peripheral Neuropathy

  NCT07911410· Qilu Hospital of Shandong University· Source

• Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes

  NCT06745544· Aalborg University Hospital· Source

• Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· University of Michigan· Source

• Neural Mobilization vs Cervical Neuromodulation in DPN

  NCT07537270· Abeer Abdrabo· Source

• Activity Reduction vs Advice for Plantar Hotspots in Diabetes

  NCT07840300· Shifa International Hospital· Source

• A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

  NCT06797869· Novo Nordisk A/S· Source

• Vitamin D in Diabetic Neuropathy

  NCT07644520· Tanta University· Source

• Peripheral Magnetic Stimulation With Balance Training to Decrease Fall Risks in Diabetic Polyneuropathy

  NCT07000214· Queen Savang Vadhana Memorial Hospital, Thailand· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 14
• Mendelian Randomization Analysis 13
• CRISPR-Cas Systems 1
• Gene Expression Profiling 32
• Sequence Analysis, RNA 3
• Whole Genome Sequencing 4
• Proteomics 10
• Metabolomics 5
• Mass Spectrometry 1
• Immunohistochemistry 1
• Magnetic Resonance Imaging 14
• Machine Learning 32
• Deep Learning 12
• Cohort Studies 48
• Genome-Wide Association Study 9

See which targets of this disease your abstract mentions, and go to the people working on them.